In a retrospective study [32] on 57 and 16 cases with GBM and grade III gliomas, respectively, all GBM tumors expressed HER2 (2+ and 3+) highly and all secondary GBM tumors with low intensity (0 and 1+). This evidence concerns the gene ERBB2 and glioblastoma.